HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit.

Abstract
Palivizumab is currently licensed for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in infants and children with chronic lung disease, with a history of preterm birth, or with haemodynamically significant congenital heart disease, but its routine use during outbreaks in neonatal intensive care units (NICUs) is not currently recommended. Here we report an outbreak in a NICU detected during a screening trial for RSV infection using a rapid antigen test (Respi-Strip((R))). Eleven preterm infants in our NICU tested positive for RSV during January 2009. Subsequent testing of the remaining infants in the NICU revealed two additional asymptomatic cases. In addition to precautions against cross-infection, palivizumab prophylaxis was administered to the remaining 37 premature infants. Two days after treatment, RSV was detected in two additional infants who had become symptomatic. To our knowledge this is the largest RSV outbreak in a NICU to be identified at an early stage by rapid testing and effectively controlled by infection control measures and palivizumab prophylaxis.
AuthorsE A Dizdar, C Aydemir, O Erdeve, F N Sari, S Oguz, N Uras, U Dilmen
JournalThe Journal of hospital infection (J Hosp Infect) Vol. 75 Issue 4 Pg. 292-4 (Aug 2010) ISSN: 1532-2939 [Electronic] England
PMID20299133 (Publication Type: Journal Article)
CopyrightCopyright 2010 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Palivizumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents (therapeutic use)
  • Cross Infection (prevention & control)
  • Disease Outbreaks
  • Early Diagnosis
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (diagnosis, epidemiology, prevention & control, virology)
  • Intensive Care Units, Neonatal
  • Male
  • Mass Screening (methods)
  • Palivizumab
  • Respiratory Syncytial Virus Infections (diagnosis, epidemiology, prevention & control)
  • Respiratory Syncytial Viruses (isolation & purification)
  • Turkey (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: